Loading...
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
BACKGROUND: Schizophrenia is a chronic and debilitating neuropsychiatric disorder that often requires long-term pharmacotherapy to manage symptoms and prevent relapse. Cariprazine is a potent dopamine D(3) and D(2) receptor partial agonist that is FDA-approved in the US for the treatment of schizoph...
Na minha lista:
| Udgivet i: | BMC Psychiatry |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571492/ https://ncbi.nlm.nih.gov/pubmed/28836957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-017-1459-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|